HPDL
Basic information
Region (hg38): 1:45326895-45328710
Previous symbols: [ "GLOXD1" ]
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities (Moderate), mode of inheritance: AR
- neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities (Strong), mode of inheritance: AR
- Leigh syndrome (Moderate), mode of inheritance: AR
- neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities; Spastic paraplegia 83, autosomal recessive | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Neurologic | 32707086; 33188300; 33970200 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (5 variants)
- Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities (4 variants)
- Spastic paraplegia (3 variants)
- not provided (2 variants)
- Spastic ataxia (1 variants)
- Spastic paraplegia 83, autosomal recessive (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HPDL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 32 | 42 | ||||
nonsense | 2 | |||||
start loss | 1 | |||||
frameshift | 11 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 9 | 11 | 33 | 5 | 3 |
Highest pathogenic variant AF is 0.0000197
Variants in HPDL
This is a list of pathogenic ClinVar variants found in the HPDL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-45327151-G-C | Spastic paraplegia • Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities • Inborn genetic diseases | Pathogenic/Likely pathogenic (Oct 20, 2023) | ||
1-45327175-C-A | Spastic paraplegia | Likely pathogenic (May 10, 2021) | ||
1-45327180-T-C | Inborn genetic diseases | Uncertain significance (Feb 06, 2024) | ||
1-45327197-G-A | Inborn genetic diseases | Uncertain significance (Dec 12, 2024) | ||
1-45327239-T-C | - | no classification for the single variant (-) | ||
1-45327242-C-T | Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities • Inborn genetic diseases | Pathogenic/Likely pathogenic (May 22, 2023) | ||
1-45327248-C-G | Inborn genetic diseases | Likely benign (Feb 03, 2025) | ||
1-45327257-C-T | Inborn genetic diseases | Uncertain significance (Aug 12, 2024) | ||
1-45327258-G-C | Spastic paraplegia | Likely pathogenic (May 10, 2021) | ||
1-45327267-A-C | Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities | Uncertain significance (Jul 21, 2022) | ||
1-45327282-T-A | Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities • HPDL-related disorder | Conflicting classifications of pathogenicity (Apr 01, 2025) | ||
1-45327295-C-A | Inborn genetic diseases • Spastic ataxia | Conflicting classifications of pathogenicity (Jul 12, 2022) | ||
1-45327297-G-A | Spastic paraplegia 83, autosomal recessive • Spastic paraplegia • Spastic ataxia • Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities | Pathogenic (Apr 01, 2025) | ||
1-45327299-G-A | Inborn genetic diseases | Uncertain significance (Oct 17, 2023) | ||
1-45327307-CTT-C | Inborn genetic diseases | Pathogenic (Aug 05, 2022) | ||
1-45327358-T-G | Inborn genetic diseases | Uncertain significance (Mar 20, 2024) | ||
1-45327362-C-A | Inborn genetic diseases | Uncertain significance (Apr 12, 2023) | ||
1-45327379-C-A | Uncertain significance (May 17, 2023) | |||
1-45327380-G-A | Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities • Spastic paraplegia | Pathogenic/Likely pathogenic (Nov 22, 2021) | ||
1-45327380-G-T | Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities | Uncertain significance (Jan 20, 2023) | ||
1-45327386-A-G | Inborn genetic diseases | Uncertain significance (Sep 15, 2021) | ||
1-45327402-T-G | Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities | Uncertain significance (Nov 22, 2023) | ||
1-45327402-TG-T | Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities • Spastic paraplegia | Pathogenic/Likely pathogenic (Sep 03, 2021) | ||
1-45327423-C-T | Inborn genetic diseases | Uncertain significance (Dec 13, 2023) | ||
1-45327487-G-C | Inborn genetic diseases | Uncertain significance (Sep 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HPDL | protein_coding | protein_coding | ENST00000334815 | 1 | 1803 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000226 | 0.511 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.933 | 197 | 237 | 0.830 | 0.0000150 | 2311 |
Missense in Polyphen | 63 | 80.043 | 0.78708 | 910 | ||
Synonymous | 1.21 | 100 | 117 | 0.858 | 0.00000831 | 861 |
Loss of Function | 0.592 | 8 | 10.0 | 0.798 | 6.56e-7 | 78 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May have dioxygenase activity. {ECO:0000305}.;
Recessive Scores
- pRec
- 0.157
Intolerance Scores
- loftool
- 0.623
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.35
Haploinsufficiency Scores
- pHI
- 0.0598
- hipred
- N
- hipred_score
- 0.272
- ghis
- 0.541
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.313
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hpdl
- Phenotype
Gene ontology
- Biological process
- aromatic amino acid family metabolic process;oxidation-reduction process
- Cellular component
- Molecular function
- 4-hydroxyphenylpyruvate dioxygenase activity;metal ion binding